Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial
Jose Luis Vazquez Martinez
- 3 May 2022
Source:
Highlights
- •Motivational recovery coaching was well-received during periods of instability.
- •MySafeRx intervention participants reported high levels of acceptability.
- •Despite high platform acceptability, adherence monitoring did not have broad appeal.
- •Recruitment was increasingly difficult as B/N prescribing became more widespread.
- ISSUP members can join Networks to comment – Sign in or become a member